Protein kinase C is not involved in the desensitization of platelet activating factor receptor in rabbit platelets.
Rabbit platelets pretreated with platelet activating factor (PAF) became refractory to further stimulation by PAF. The effect was specific for PAF. In this study, the alteration in the specific agonist binding to PAF receptor in platelets following desensitization was investigated. As revealed by the Scatchard analysis of radioligand binding data, the affinity for specific PAF binding to desensitized platelet membranes was substantially lowered as compared with that to control platelet membranes. Guanine nucleotide triphosphate, which was shown to decrease the affinity of specific PAF binding to platelet membranes, had less effect on the PAF binding affinity to the desensitized preparation. In platelets pretreated with phorbol 12-myristate-13-acetate, the binding affinity of PAF receptor remained unaltered. Pretreatment of platelets with 1-(5-isoquinolinesulphonyl)-2-methylpiperazine, a protein kinase C inhibitor, or neomycin, an inhibitor of the polyphosphoinositide breakdown, failed to prevent the reduction of specific PAF binding affinity following subsequent exposure to PAF. These results suggest that the agonist-induced desensitization of PAF receptor in rabbit platelets is independent of activation of protein kinase C.
Chau
L Y
LY
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000818:Animals; D001792:Blood Platelets / Q000502:physiology*; D002462:Cell Membrane / Q000502:physiology; D006160:Guanosine Triphosphate / Q000494:pharmacology; D007295:Inositol Phosphates / Q000097:blood*; D007546:Isoquinolines / Q000494:pharmacology; D007700:Kinetics; D009355:Neomycin / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000378:metabolism / Q000494:pharmacology*; D010980:Platelet Membrane Glycoproteins; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000097:blood*; D011817:Rabbits; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000502:physiology*; D043562:Receptors, G-Protein-Coupled; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D007295:Inositol Phosphates; D007546:Isoquinolines; D010879:Piperazines; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D006160:Guanosine Triphosphate; D011493:Protein Kinase C; D009355:Neomycin; D013755:Tetradecanoylphorbol Acetate